Baseline and dynamic plasma chromogranin A (CgA) level to predict clinical outcome and tumor response in Asian patients with gastroenteropancreatic neuroendocrine tumor (GEP-NET).

被引：0
|
作者：
Chou, Wen-Chi [1 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Taoyuan, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15151
引用
收藏
页数：1
相关论文
共 39 条
  • [1] Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
    Phillips, William J.
    Pradier, Michelle
    Goodwin, Rachel
    Vickers, Michael
    Asmis, Tim
    CURRENT ONCOLOGY, 2024, 31 (02) : 952 - 961
  • [2] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [3] Survivin protein detection is a promising biomarker in the serum of gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients
    Georgieva, Inna
    Hein, Sibyll
    Wang, Yawen
    Kiewe, Philipp
    Hopfenmuller, Werner
    Blaker, Michael
    Zeitz, Martin
    Grabowski, Patricia
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [4] The Plasma Chromogranin A Level Predicts Survival and Tumor Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Chou, W. C.
    Chen, J. S.
    Hsu, J. T.
    Chen, T. C.
    Hung, Y. S.
    Sun, C. F.
    Hwang, T. L.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 253 - 253
  • [5] Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Chou, Wen-Chi
    Chen, Jen-Shi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Tse-Ching
    Sun, Chien-Feng
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    ANTICANCER RESEARCH, 2014, 34 (10) : 5661 - 5669
  • [6] Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
    Kim, Seung Tae
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Lee, Jeeyun
    Park, Young Suk
    JOURNAL OF CANCER, 2016, 7 (09): : 1044 - 1048
  • [7] Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in Precision-Medicine Era
    Kim, S.
    Yoo, K.
    Jung, K.
    Lee, S.
    Lee, J.
    Park, S.
    Park, J.
    Lim, H.
    Kang, W.
    Park, Y.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 85 - 86
  • [8] Quantitative Detection of Survivin Protein in the Serum of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients - A Promising Biomarker?
    Georgieva, I
    Blaeker, M.
    Wang, Y.
    Kiewe, P.
    Zeitz, M.
    Grabowski, P.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 114 - 114
  • [9] Chromogranin A (CgA) in the Diagnosis and Monitoring of Patients with Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NET): A Single-Institution Experience
    Massironi, S.
    Rossi, R. E.
    Spampatti, M. P.
    Casazza, G.
    Conte, D.
    Ciafardini, C.
    Cavalcoli, F.
    Peracchi, M.
    NEUROENDOCRINOLOGY, 2012, 96 : 48 - 48
  • [10] An Observational Registry Collecting Data on Gastroenteropancreatic Neuroendocrine Tumor Patients (GEP-NET Registry) in the Middle East and Asia
    Hwang, T. L.
    Lang, B.
    Ovartlarnporn, B.
    Park, Y. S.
    Katta, J.
    Abbassi, S.
    Poon, D.
    NEUROENDOCRINOLOGY, 2011, 94 : 27 - 27
1234